Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ZEKE CAPITAL ADVISORS LLC | 11-14-2022 | 09-30-2022 | 725 | 1,373,357,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ASCENDIS PHARMA A/S SPONSORED ADR | ADR | 451 | $398,000 | 3,851 | 0.03 | 0.02 | 0 | 0.00 | 09-30-2022 |
Gilead Sciences Inc | Stock | 452 | $397,000 | 6,445 | 0.03 | 0.02 | -16 | -0.25 | 09-30-2022 |
Marsh & McLennan Cos Inc | Stock | 453 | $396,000 | 2,648 | 0.03 | 0.02 | 589 | 28.61 | 09-30-2022 |
BB&T Corp Com | Stock | 454 | $391,000 | 9,000 | 0.03 | 0.03 | -132 | -1.45 | 09-30-2022 |